Vanderbilt Wins $10M from NCRR to Establish Proteomics Imaging Resource
April 08, 2011
Vanderbilt Wins $10M from NCRR to Establish Proteomics Imaging Resource
A portion of the funding will go toward the purchase of a new MALDI TOF-TOF MS-MS machine from upstart mass spec firm Virgin Instruments, a company founded by Marvin Vestal, the former president of mass spectrometry platform R&D at Applied Biosystems and developer of the first commercial MALDI-TOF mass spec.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- New Instruments, Applications Powering Rise of MALDI-MS as Clinical Proteomics Platform
January 20, 2012 / ProteoMonitor - Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor - Expanded Proximity Ligation Assay Could Prove Valuable for Biomarker Studies, Top-Down Proteomics
May 13, 2011 / ProteoMonitor - SERI Using TripleTOF 5600 to Validate Protein Biomarker for Dry Eye Syndrome
May 6, 2011 / ProteoMonitor - Celera's Proteomics Program Focuses on Biomarker-Based Lung Cancer Test
April 15, 2011 / ProteoMonitor